Ambalal Sarabhai Enterprises Faces Mixed Performance Amid Stake Increase by Promoters
Ambalal Sarabhai Enterprises has experienced a recent evaluation adjustment, reflecting its position in the pharmaceuticals sector. Despite a significant annual increase in operating profit, the company faces challenges in management efficiency and valuation, while promoters have increased their stake, indicating ongoing commitment.
Ambalal Sarabhai Enterprises has recently undergone an adjustment in evaluation, reflecting the company's current standing in the pharmaceuticals and drugs sector. This revision comes amidst a backdrop of mixed performance indicators. While the company has reported a notable annual increase in operating profit, averaging 51.61%, it continues to face challenges related to management efficiency, as evidenced by a Return on Capital Employed (ROCE) of 4.35%. The stock's market position appears to be under pressure, with technical indicators suggesting a bearish sentiment. Additionally, the valuation metrics indicate that the stock may be perceived as expensive, particularly with an enterprise value to capital employed ratio of 2.5. Despite these challenges, the promoters have shown a commitment to the company by increasing their stake by 0.58%, now holding 31.35%.
Overall, the adjustment in evaluation highlights the complexities surrounding Ambalal Sarabhai Enterprises, balancing strong growth in operating profit against concerns regarding efficiency and valuation.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
